These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35039431)

  • 1. Integrating Buprenorphine Treatment for Opioid Use with Primary Care is Associated with Greater Retention in Treatment.
    Mirer AG; Tiemstra JD; Hammes NE; Cloum HM; LaFavor KJ
    J Am Board Fam Med; 2022; 35(1):206-208. PubMed ID: 35039431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment.
    Justesen K; A Hooker S; Sherman MD; Lonergan-Cullum M; Nissly T; Levy R
    J Am Board Fam Med; 2020; 33(6):848-857. PubMed ID: 33219064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Medication-Assisted Therapy with New Onset of Cardiac Arrhythmia in Patients Diagnosed with Opioid Use Disorders.
    Raji MA; Priyadarshni S; Yu X; Digbeu B; Kuo YF
    Am J Med; 2022 Jul; 135(7):864-870.e3. PubMed ID: 35139325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
    Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
    J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
    Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L
    Mol Psychiatry; 2019 Dec; 24(12):1868-1883. PubMed ID: 29934549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.
    Zheng W; Nickasch M; Lander L; Wen S; Xiao M; Marshalek P; Dix E; Sullivan C
    J Addict Med; 2017; 11(2):138-144. PubMed ID: 28107210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing Office-Based Opioid Treatment Models in Primary Care.
    Brooks EM; Tong S
    J Am Board Fam Med; 2020; 33(4):512-520. PubMed ID: 32675262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
    McElrath K; Joseph H
    Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine.
    Weintraub E; Greenblatt AD; Chang J; Himelhoch S; Welsh C
    Am J Addict; 2018 Dec; 27(8):612-617. PubMed ID: 30265425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice.
    Cope K; DeMicco J; Salib J; Michael M; Yakoub P; Daoud K; Cope R
    J Addict Med; 2022 Nov-Dec 01; 16(6):716-721. PubMed ID: 35913992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Balance Between Serving the Community and the Reality of Treating Opioid Use Disorder in Rural Primary Care Practices.
    Holtrop JS; Mullen R; Curcija K; Westfall JM; Zittleman L
    J Health Care Poor Underserved; 2022; 33(1):253-267. PubMed ID: 35153218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
    Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
    Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating perinatal opioid use disorder in rural settings: Challenges and opportunities.
    Higgins TM; Goodman DJ; Meyer MC
    Prev Med; 2019 Nov; 128():105786. PubMed ID: 31356827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost.
    Hsu YJ; Marsteller JA; Kachur SG; Fingerhood MI
    Popul Health Manag; 2019 Aug; 22(4):292-299. PubMed ID: 30543495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
    Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
    Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Primary Care Utilization of Medication-Assisted Treatment (MAT) for Opioid Use Disorder.
    Gardner-Buckshaw SL; Perzynski AT; Spieth R; Khaira P; Delos Reyes C; Novak L; Kropp D; Caron A; Boltri JM
    J Am Board Fam Med; 2023 Apr; 36(2):251-266. PubMed ID: 36948541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
    Wilder C; Lewis D; Winhusen T
    Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder.
    Berry ARW; Finlayson TL; Mellis LM; Urada LA
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.